NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
MREO Mereo BioPharma
- 3.3500
- +0.0600+1.82%
Close Dec 20 16:00 ET
- 3.3500
- 0.00000.00%
Post 16:00 ET
519.74MMarket Cap-11.17P/E (TTM)
3.3900High3.1100Low1.76MVolume3.2800Open3.2900Pre Close5.80MTurnover1.76%Turnover RatioLossP/E (Static)155.15MShares5.020052wk High7.16P/B336.35MFloat Cap2.150052wk Low--Dividend TTM100.40MShs Float8.4800Historical High--Div YieldTTM8.51%Amplitude0.3010Historical Low3.2890Avg Price1Lot Size
About Mereo BioPharma Company
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
Company Profile
SymbolMREO
Company NameMereo BioPharma
Listing DateApr 24, 2019
Issue Price17.62
Founded2015
CEODr. Denise Vera Scots-Knight, PhD
MarketNASDAQ
Employees33
Securities TypeDR
ADS Ratio1.0 : 5.0
Fiscal Year Ends12-31
Address1 Cavendish Place,4th Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1G 0QF
Phone44-333-023-7300
Company Executives
- Name
- Position
- Salary
- Dr. Denise Vera Scots-Knight, PhD
- Executive Director,Chief Executive Officer
- 2.22M
- Michael Stephen Wyzga
- Non-Executive Director,Chairman
- 156.80K
- Marc J. Yoskowitz
- Non-Executive Director
- 94.49K
- Dr. Annalisa Mary Jenkins
- Non-Executive Director
- 100.96K
- Pierre Jacquet
- Non-Executive Director
- 102.18K
- Dr. Jeremy Bender
- Non-Executive Director
- 105.08K
- Dr. Anders Olof Adolf Ekblom
- Non-Executive Director
- 121.31K
- Justin Roberts
- Non-Executive Director
- --
- Daniel Shames
- Non-Executive Director
- 97.75K
- Dr. Deepika Rachel Pakianathan
- Non-Executive Director
- 113.76K
- Charles Sermon
- General Counsel & Company Secretary
- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.